118 related articles for article (PubMed ID: 34743410)
1. The role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL-33 signaling axis.
Ohta S; Tago K; Kuchimaru T; Funakoshi-Tago M; Horie H; Aoki-Ohmura C; Matsugi J; Yanagisawa K
FEBS J; 2022 Apr; 289(7):1950-1967. PubMed ID: 34743410
[TBL] [Abstract][Full Text] [Related]
2. Intracellular NF-HEV/IL-33 harbors essential roles in Ras-induced cellular transformation by contributing to cyclin D1 protein synthesis.
Ohta S; Tago K; Funakoshi-Tago M; Matsugi J; Yanagisawa K
Cell Signal; 2016 Aug; 28(8):1025-36. PubMed ID: 27155324
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation.
Tago K; Funakoshi-Tago M; Ohta S; Kawata H; Saitoh H; Horie H; Aoki-Ohmura C; Yamauchi J; Tanaka A; Matsugi J; Yanagisawa K
Mol Oncol; 2019 Nov; 13(11):2493-2510. PubMed ID: 31580526
[TBL] [Abstract][Full Text] [Related]
4. MerTK mediates STAT3-KRAS/SRC-signaling axis for glioma stem cell maintenance.
Eom H; Kaushik N; Yoo KC; Shim JK; Kwon M; Choi MY; Yoon T; Kang SG; Lee SJ
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):87-95. PubMed ID: 29553850
[TBL] [Abstract][Full Text] [Related]
5. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.
Cummings CT; Zhang W; Davies KD; Kirkpatrick GD; Zhang D; DeRyckere D; Wang X; Frye SV; Earp HS; Graham DK
Mol Cancer Ther; 2015 Sep; 14(9):2014-22. PubMed ID: 26162689
[TBL] [Abstract][Full Text] [Related]
7. MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
Schlegel J; Sambade MJ; Sather S; Moschos SJ; Tan AC; Winges A; DeRyckere D; Carson CC; Trembath DG; Tentler JJ; Eckhardt SG; Kuan PF; Hamilton RL; Duncan LM; Miller CR; Nikolaishvili-Feinberg N; Midkiff BR; Liu J; Zhang W; Yang C; Wang X; Frye SV; Earp HS; Shields JM; Graham DK
J Clin Invest; 2013 May; 123(5):2257-67. PubMed ID: 23585477
[TBL] [Abstract][Full Text] [Related]
8. MerTK negatively regulates Staphylococcus aureus induced inflammatory response via SOCS1/SOCS3 and Mal.
Zahoor A; Yang C; Yang Y; Akhtar M; Umar T; Khan MA; Ahmad S; Deng G; Guo MY
Immunobiology; 2020 Jul; 225(4):151960. PubMed ID: 32747017
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane rescues amyloid-β peptide-mediated decrease in MerTK expression through its anti-inflammatory effect in human THP-1 macrophages.
Jhang KA; Park JS; Kim HS; Chong YH
J Neuroinflammation; 2018 Mar; 15(1):75. PubMed ID: 29530050
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the interleukin-11 gene by oncogenic Ras.
Shin SY; Choi C; Lee HG; Lim Y; Lee YH
Carcinogenesis; 2012 Dec; 33(12):2467-76. PubMed ID: 23027619
[TBL] [Abstract][Full Text] [Related]
11. Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development.
Pipitone RM; Calvaruso V; Di Marco L; Di Salvo F; Gaggianesi M; Lupo G; Zito R; La Mantia C; Ramazzotti M; Petta S; Di Marco V; Craxì A; Grimaudo S
Front Immunol; 2022; 13():926236. PubMed ID: 36003399
[TBL] [Abstract][Full Text] [Related]
12. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC.
Giroud P; Renaudineau S; Gudefin L; Calcei A; Menguy T; Rozan C; Mizrahi J; Caux C; Duong V; Valladeau-Guilemond J
Front Immunol; 2020; 11():564133. PubMed ID: 33101282
[TBL] [Abstract][Full Text] [Related]
13. Potential Oncogenic Effect of the MERTK-Dependent Apoptotic-Cell Clearance Pathway in Starry-Sky B-Cell Lymphoma.
Farnworth-McHugh S; Barth N; Melville L; Paterson M; Lynch C; Holland P; Dransfield I; Gregory C
Front Immunol; 2020; 11():1759. PubMed ID: 32973744
[TBL] [Abstract][Full Text] [Related]
14. N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth.
Liu Y; Lan L; Li Y; Lu J; He L; Deng Y; Fei M; Lu JW; Shangguan F; Lu JP; Wang J; Wu L; Huang K; Lu B
Redox Biol; 2022 Aug; 54():102366. PubMed ID: 35728303
[TBL] [Abstract][Full Text] [Related]
15. MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type
Yan D; Parker RE; Wang X; Frye SV; Earp HS; DeRyckere D; Graham DK
Clin Cancer Res; 2018 Dec; 24(24):6523-6535. PubMed ID: 30194074
[TBL] [Abstract][Full Text] [Related]
16. MerTK Expression and ERK Activation Are Essential for the Functional Maturation of Osteopontin-Producing Reparative Macrophages After Myocardial Infarction.
Shirakawa K; Endo J; Kataoka M; Katsumata Y; Anzai A; Moriyama H; Kitakata H; Hiraide T; Ko S; Goto S; Ichihara G; Fukuda K; Minamino T; Sano M
J Am Heart Assoc; 2020 Sep; 9(18):e017071. PubMed ID: 32865099
[TBL] [Abstract][Full Text] [Related]
17. Effects of MERTK Inhibitors UNC569 and UNC1062 on the Growth of Acute Myeloid Leukaemia Cells.
Koda Y; Itoh M; Tohda S
Anticancer Res; 2018 Jan; 38(1):199-204. PubMed ID: 29277773
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.
Pollock CB; Shirasawa S; Sasazuki T; Kolch W; Dhillon AS
Cancer Res; 2005 Feb; 65(4):1244-50. PubMed ID: 15735008
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
Yamada H; Omata-Yamada T; Lengyel P
J Biol Chem; 1991 Feb; 266(6):4002-9. PubMed ID: 1995648
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.
Li C; McClellan SA; Barrett R; Hazlett LD
Invest Ophthalmol Vis Sci; 2014 Oct; 55(10):6886-900. PubMed ID: 25298414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
